Concepedia
Statistics
Publications
7
Citations
178
H-Index
Active since
2009
Affiliations
Bayer (United States)(Current)
University of Pennsylvania
Bayer (Germany)
University of Connecticut
University of Southern California
Muralikrishna Tangirala is an author at Bayer (United States) specializing in medicine, clinical pharmacology, and pharmacotherapy.
Publications per year
2009–2016
Are women benefiting from the Affordable Care Act? A real-world evaluation of the impact of the Affordable Care Act on out-of-pocket costs for contraceptives
Lizhi Wen, Jay Lin, Muralikrishna Tangirala et al. · Contraception · 2016 · 40 citations
Medicine, Health Policy, Social Policy +17
Medication adherence to rivaroxaban and dabigatran for stroke prevention in patients with non-valvular atrial fibrillation in the United States
Craig I Coleman, Muralikrishna Tangirala, Thomas Evers · International Journal of Cardiology · 2016 · 35 citations
Medicine, Cardiology, Pharmacotherapy +16
Treatment Persistence and Discontinuation with Rivaroxaban, Dabigatran, and Warfarin for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation in the United States
Craig I Coleman, Muralikrishna Tangirala, Thomas Evers · PLoS ONE · 2016 · 33 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +17
Real-world comparative outcomes of US type 2 diabetes patients initiating analog basal insulin therapy
Keith L. Davis, Muralikrishna Tangirala, Juliana Meyers et al. · Current Medical Research and Opinion · 2013 · 32 citations
Medicine, Endocrinology, Internal Medicine +15
Cost and resource utilization comparisons of second-generation antihistamines vs. montelukast for allergic rhinitis treatment
Joel W. Hay, Mehul Jhaveri, Muralikrishna Tangirala et al. · Allergy and Asthma Proceedings · 2009 · 14 citations
Pharmacy, Pharmacoeconomics, Pharmacotherapy +17
1–5 of 7